| Autor: |
Lynn Ghijselings, Irina Verbakel, Dirk Van de Putte, François Hervé, An-Sofie Goessaert, Kim Pauwaert, Stefan Engelberg, Ubi Van den Hombergh, D. Beeckman, Piet Pattyn, Karel Everaert |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Continence, Vol 6, Iss , Pp 100701- (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2772-9737 |
| DOI: |
10.1016/j.cont.2023.100701 |
| Popis: |
Aim:: I. To describe the number of false positive cases (FP), their characteristics and reason of occurrence in sacral neuromodulation therapy (SNM). Methods:: A multidisciplinary prospective single-centre study was conducted between March 2018 and December 2021 with a follow-up of 12 months. Patients with therapy-resistant pelvic organ dysfunctions, scheduled for a 2-staged SNM procedure at the Urology (UD) and Colorectal Surgery Department (CRD), were included. All patients completed bowel and bladder diaries at baseline and during the test phase. Patient global impression of change (PGIC) and satisfaction scores concerning urological (US) and bowel symptoms (BS) were surveyed at baseline, at 1, 6 and 12 months after implantation. Patient characteristics and diary outcomes between FP and true positive cases (TP) were compared using non-parametric statistical tests. SPSS 27.0 was used. Clinical trial registration: NCT05313984. Results:: The FP ratio at one month follow-up was 16% (11/68), with a FP ratio of 13% (N=6/48) and 25% (N=5/20) for the urology patients and colorectal surgery patients, respectively. There were no significant differences in demographic characteristics between the FP and TP group (p > 0,05), however there is a trend towards FP having worse baseline symptoms than TP. The FP group had a significant lower baseline and test phase 24 h diuresis (p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
